Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
42.25
+0.76 (1.83%)
At close: Dec 20, 2024, 4:00 PM
42.80
+0.55 (1.30%)
After-hours: Dec 20, 2024, 7:53 PM EST
Viking Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
27
Market Cap
4.71B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Integer Holdings | 1.71B |
Alkermes | 1.51B |
Tempus AI | 640.44M |
ADMA Biologics | 382.81M |
Axsome Therapeutics | 338.46M |
TG Therapeutics | 264.79M |
Krystal Biotech | 241.52M |
BridgeBio Pharma | 217.77M |
VKTX News
- 2 days ago - Viking Therapeutics: Competition Fears Are Exaggerated - Seeking Alpha
- 2 days ago - Viking Therapeutics: Holiday Gift - Seeking Alpha
- 3 days ago - What's Going On With Viking Therapeutics Stock On Wednesday? - Benzinga
- 16 days ago - Viking Stock Pops, Then Drops On Latest Obesity / MASH Data - Why I'm Still Bullish - Seeking Alpha
- 22 days ago - Viking Therapeutics Stock On Brink Of Death Cross As Weight Loss Hype Loses Momentum - Benzinga
- 25 days ago - Biden Proposes Medicare, Medicaid Access For Popular Weight-Loss Drugs - Benzinga
- 4 weeks ago - Viking Therapeutics Garners Analyst Support For NASH And Metabolic Programs - Benzinga
- 4 weeks ago - Viking Therapeutics is more than just a weight-loss stock, and that's drawing cheers - Market Watch